COVID19

MPR Weekly Dose Podcast Episode 36

This pod covers important news regarding hydroxychloroquine; The efficacy of dietary supplements as a means to manage or prevent COVID-19; The first non-hormonal contraceptive gel approved by the FDA; And an expanded approval for dupilumab.

Hydroxychloroquine or Chloroquine for COVID-19: Large Study Finds No Benefit

Editor’s Note: The following article was based on published research that has recently been retracted by The Lancet due to concerns over data integrity. The full retraction statement can be found here. A multinational observational study evaluating the use of hydroxychloroquine or chloroquine, either as monotherapy or with a macrolide, found that these treatments may increase…

MPR Weekly Dose Podcast Episode 35

This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott’s diagnostic test; the immune globulin therapy linked to recovery in multisystem inflammatory syndrome in children, related to COVID-19; and the clinical trials set to be initiated for an umbilical cord stem cell therapy and a high dose IV immune globulin…